概括
高剂量的desferrioxamine治疗贝塔沙拉西米亚重症患者的铁过载导致视网膜异常. 这些视力问题在停止铁化疗法后得到改善.
科学领域:
- 血液学 血液学 血液学
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
背景情况:
- 大型贝塔血症需要频繁的输血,导致铁过载.
- 铁过载带来了重大风险,包括潜在的器官损伤.
研究的目的:
- 为了评估高于正常的静脉注射德斯费里奥克萨明剂量的疗效和安全性.
- 评估密集化铁对输血依赖患者的影响.
- 为了确定高剂量德斯费里奥克萨治疗的潜在不良影响.
主要方法:
- 四名患有贝塔沙拉西米亚重症的患者在升级剂量下接受了静脉注射德斯费里克萨.
- 治疗旨在抵消大量输血引起的铁过载.
- 临床监测包括眼科检查以检测不良影响.
主要成果:
- 两名患者出现了视网膜异常,其特征是夜盲和视野缺陷.
- 这些眼科发现与高剂量的desferrioxamine管理有关.
- 停止使用desferrioxamine导致视网膜异常和视觉症状的改善.
结论:
- 静脉注射desferrioxamine,即使是高剂量,也可能诱导可逆的视网膜毒性在beta thalassaemia重症患者.
- 在密集的铁化疗法期间,仔细的眼科监测至关重要.
- 剂量调整或药物停止可能是必要的,以管理desferrioxamine引起的视力障碍.
相关概念视频
Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...


